DuPont (DD) - Get DuPont de Nemours, Inc. Report was upgraded to outperform at Wells Fargo. Analysts see upside, given significant synergy opportunities from its merger with Dow Chemical (DOW) - Get Dow, Inc. Report , Wells said.
Hewlett-Packard Enterprises (HPE) - Get Hewlett Packard Enterprise Co. Report was upgraded to outperform from neutral at Credit Suisse. $21 price target. The company can effectively manage the transition to become a cloud supplier, Credit Suisse said.
Kimberly-Clark (KMB) - Get Kimberly-Clark Corporation Report was upgraded to buy from neutral at Goldman Sachs. $155 price target. The company was also placed on the conviction buy list. Organic sales growth should remain resilient, Goldman said.
Mead Johnson (MJN) was downgraded to neutral at Goldman Sachs. $86 price target. International challenges persist and the domestic business is now faltering, Goldman said.
Match (MTCH) - Get Match Group, Inc. Report was initiated with a sell rating at Goldman Sachs. $12 price target. Growth has been primarily through acquisitions rather than improved monetization, Goldman said.
Match was initiated with an overweight rating at Barclays. $17 price target. New brands should reaccelerate sales growth and significantly expand margins, Barclays said.
Square was initiated with a buy rating at Goldman Sachs said. $16 price target. The company is looking to expand and monetize its small business footprint, Goldman said.
Stryker (SYK) - Get Stryker Corporation Report was downgraded to underperform from market perform at BMO Capital. $88 price target. The valuation is less attractive, given the company's growth headwinds, BMO said.
This article was written by a staff member of TheStreet.